Annual Current Liabilities
$31.21 M
+$7.30 M+30.51%
31 December 2023
Summary:
UroGen Pharma annual total current liabilities is currently $31.21 million, with the most recent change of +$7.30 million (+30.51%) on 31 December 2023. During the last 3 years, it has risen by +$9.78 million (+45.61%). URGN annual current liabilities is now at all-time high.URGN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$32.79 M
-$1.44 M-4.20%
30 September 2024
Summary:
UroGen Pharma quarterly total current liabilities is currently $32.79 million, with the most recent change of -$1.44 million (-4.20%) on 30 September 2024. Over the past year, it has increased by +$7.00 million (+27.14%). URGN quarterly current liabilities is now -4.20% below its all-time high of $34.22 million, reached on 30 June 2024.URGN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +30.5% | +27.1% |
3 y3 years | +45.6% | +65.5% |
5 y5 years | +131.8% | +132.7% |
URGN Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +45.6% | -4.2% | +81.8% |
5 y | 5 years | at high | +131.8% | -4.2% | +132.7% |
alltime | all time | at high | +1295.3% | -4.2% | +945.2% |
UroGen Pharma Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $32.79 M(-4.2%) |
June 2024 | - | $34.22 M(+29.9%) |
Mar 2024 | - | $26.34 M(-15.6%) |
Dec 2023 | $31.21 M(+30.5%) | $31.21 M(+21.0%) |
Sept 2023 | - | $25.79 M(-3.7%) |
June 2023 | - | $26.77 M(+6.1%) |
Mar 2023 | - | $25.23 M(+5.5%) |
Dec 2022 | $23.92 M(+6.9%) | $23.92 M(+25.9%) |
Sept 2022 | - | $19.00 M(+5.3%) |
June 2022 | - | $18.04 M(-5.5%) |
Mar 2022 | - | $19.09 M(-14.7%) |
Dec 2021 | $22.38 M(+4.4%) | $22.38 M(+13.0%) |
Sept 2021 | - | $19.81 M(+3.9%) |
June 2021 | - | $19.06 M(+12.1%) |
Mar 2021 | - | $17.00 M(-20.7%) |
Dec 2020 | $21.44 M | $21.44 M(+21.7%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $17.62 M(+7.3%) |
June 2020 | - | $16.42 M(+15.6%) |
Mar 2020 | - | $14.21 M(-27.1%) |
Dec 2019 | $19.48 M(+44.7%) | $19.48 M(+38.3%) |
Sept 2019 | - | $14.09 M(+18.9%) |
June 2019 | - | $11.84 M(+15.2%) |
Mar 2019 | - | $10.28 M(-23.7%) |
Dec 2018 | $13.46 M(+91.4%) | $13.46 M(+50.0%) |
Sept 2018 | - | $8.97 M(+12.9%) |
June 2018 | - | $7.95 M(+43.7%) |
Mar 2018 | - | $5.54 M(-21.3%) |
Dec 2017 | $7.04 M(+124.3%) | $7.04 M(+42.8%) |
Sept 2017 | - | $4.93 M(-0.8%) |
June 2017 | - | $4.97 M(+58.3%) |
Dec 2016 | $3.14 M(+40.2%) | $3.14 M |
Dec 2015 | $2.24 M | - |
FAQ
- What is UroGen Pharma annual total current liabilities?
- What is the all time high annual current liabilities for UroGen Pharma?
- What is UroGen Pharma annual current liabilities year-on-year change?
- What is UroGen Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for UroGen Pharma?
- What is UroGen Pharma quarterly current liabilities year-on-year change?
What is UroGen Pharma annual total current liabilities?
The current annual current liabilities of URGN is $31.21 M
What is the all time high annual current liabilities for UroGen Pharma?
UroGen Pharma all-time high annual total current liabilities is $31.21 M
What is UroGen Pharma annual current liabilities year-on-year change?
Over the past year, URGN annual total current liabilities has changed by +$7.30 M (+30.51%)
What is UroGen Pharma quarterly total current liabilities?
The current quarterly current liabilities of URGN is $32.79 M
What is the all time high quarterly current liabilities for UroGen Pharma?
UroGen Pharma all-time high quarterly total current liabilities is $34.22 M
What is UroGen Pharma quarterly current liabilities year-on-year change?
Over the past year, URGN quarterly total current liabilities has changed by +$7.00 M (+27.14%)